, in periods or patients with elevated risk, more intensive treatment with clopidogrel (alone or together with aspirin) is … compared with aspirin alone and, based on an indirect comparison, also when compared with clopidogrel. Conclusions: The cost … 5 years), and clopidogrel for the treatment of symptomatic cardiovascular disease or acute coronary syndrome (for a …

unstable angina (UA). The CURE (Clopidogrel in Unstable angina to prevent Recurrent Events) trial has shown that clopidogrel …:Objective: To evaluate the cost effectiveness of 1 year of treatment with clopidogrel in addition to aspirin in NSTEMI or UA … aspirin treatment group and 8.41 years in the aspirin plus clopidogrel treatment group. The corresponding discounted QALYs …

acetylsalicylic acid (aspirin) and clopidogrel have been shown to reduce the risk of recurrent cardiovascular events in various … subgroups of patients with vascular disease. Objective: To estimate the cost effectiveness of clopidogrel versus aspirin in …. Methods: A Markov model combining clinical, epidemiological and cost data was used to assess the economic value of clopidogrel …

adverse cardiac events with clopidogrel, but not with prasugrel. The frequency of the *2 allele varies by ethnicity and … patients with generic clopidogrel compared with prasugrel, and also compared with the genetically guided strategy that *2 … allele carriers receive prasugrel and non-carriers receive clopidogrel. Abstract: Methods:Methods: A decision-tree model …

efficacy in the secondary prevention of atherothrombotic events. Although clopidogrel seems to be superior to aspirin in terms …. Abstract: Objective:Objective: The aim of this study was to conduct a cost-effectiveness analysis comparing clopidogrel with … rates reported in the CAPRIE trial. The effect of clopidogrel was applied only during the first 2 years of the model …

aspirin arm of the CAPRIE (Clopidogrel versus Aspirin in Patients at Risk of Ischaemic Events) study. Direct costs from the …

Clopidogrel (Plavix(R)) is a selective inhibitor of adenosine diphosphate-induced platelet aggregation. In patients … with acute coronary syndromes (ACS) [unstable angina or non-ST-segment elevation myocardial infarction], clopidogrel plus … plus aspirin in the well designed clinical trial CURE (Clopidogrel in Unstable angina to prevent Recurrent Events) and its …